NEO NeoGenomics, Inc.
Healthcare$9.23+1.32%ClosedMarket Cap: $240.4M
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$19.00
Target (Median)
$19.00
Target Range
$13.00 - $25.00
Upside from current price: 105.9%
Rating Distribution
2 Strong Buy6 Buy6 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-29 | Benchmark | upgrade | Buy | Hold |
| 2026-04-29 | TD Cowen | maintain | Buy | Buy |
| 2026-04-29 | Leerink Partners | upgrade | Outperform | Market Perform |
| 2026-02-24 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-02-17 | Needham | maintain | Buy | Buy |
| 2026-01-12 | Needham | maintain | Buy | Buy |
| 2025-09-12 | TD Cowen | maintain | Buy | Buy |
| 2025-09-02 | Stephens & Co. | maintain | Overweight | Overweight |
| 2025-08-29 | Needham | maintain | Buy | Buy |
| 2025-08-04 | Piper Sandler | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.36 | $880.7M | 7 |
| Sun Dec 31 | $0.50 | $964.6M | 4 |
| Mon Dec 31 | $0.62 | $1.04B | 2 |
| Tue Dec 31 | $0.82 | $1.12B | 2 |